Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

Published 2017 View Full Article

Authors

Keywords

Enzalutamide, Metastatic castration-resistant prostate cancer, Androgen receptor signaling inhibitor, Overall survival, Radiographic progression-free survival

Journal

EUROPEAN UROLOGY

Volume 71, Issue 2, Pages 151-154

Publisher

Elsevier BV

Online

2016-07-30

DOI

10.1016/j.eururo.2016.07.032

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started